1. Home
  2. EVO vs CRI Comparison

EVO vs CRI Comparison

Compare EVO & CRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVO
  • CRI
  • Stock Information
  • Founded
  • EVO 1993
  • CRI 1865
  • Country
  • EVO Germany
  • CRI United States
  • Employees
  • EVO N/A
  • CRI N/A
  • Industry
  • EVO Biotechnology: Pharmaceutical Preparations
  • CRI Apparel
  • Sector
  • EVO Health Care
  • CRI Consumer Discretionary
  • Exchange
  • EVO Nasdaq
  • CRI Nasdaq
  • Market Cap
  • EVO 1.5B
  • CRI 1.3B
  • IPO Year
  • EVO 2021
  • CRI 2003
  • Fundamental
  • Price
  • EVO $4.30
  • CRI $34.14
  • Analyst Decision
  • EVO Buy
  • CRI Sell
  • Analyst Count
  • EVO 2
  • CRI 5
  • Target Price
  • EVO $5.90
  • CRI $36.20
  • AVG Volume (30 Days)
  • EVO 154.6K
  • CRI 1.6M
  • Earning Date
  • EVO 05-06-2025
  • CRI 04-25-2025
  • Dividend Yield
  • EVO N/A
  • CRI 9.37%
  • EPS Growth
  • EVO N/A
  • CRI N/A
  • EPS
  • EVO N/A
  • CRI 4.51
  • Revenue
  • EVO $851,944,444.00
  • CRI $2,812,437,000.00
  • Revenue This Year
  • EVO $11.29
  • CRI N/A
  • Revenue Next Year
  • EVO $13.20
  • CRI N/A
  • P/E Ratio
  • EVO N/A
  • CRI $7.57
  • Revenue Growth
  • EVO 1.50
  • CRI N/A
  • 52 Week Low
  • EVO $2.84
  • CRI $32.04
  • 52 Week High
  • EVO $5.68
  • CRI $72.11
  • Technical
  • Relative Strength Index (RSI)
  • EVO 61.35
  • CRI 44.12
  • Support Level
  • EVO $3.91
  • CRI $32.42
  • Resistance Level
  • EVO $4.38
  • CRI $34.98
  • Average True Range (ATR)
  • EVO 0.13
  • CRI 1.57
  • MACD
  • EVO 0.01
  • CRI 0.18
  • Stochastic Oscillator
  • EVO 86.89
  • CRI 29.37

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About CRI Carter's Inc.

Carter's Inc makes apparel for babies and children under brand names including Carter's and OshKosh B'gosh. It sells its products through a multi-channel business model, which includes retail stores, eCommerce, and wholesale sales channels, as well as retail omnichannel capabilities in the United States and Canada, which enables it to reach a broad range of consumers around the world. The company operates in three segments; U.S. Retail, U.S. Wholesale, and International. The majority of revenue is derived from U.S. Wholesale segment. The company predominantly sources products through contract manufacturers in Asia. It has multiple distribution centers in the U.S., in addition to distribution centers in Canada and Asia that serve international customers.

Share on Social Networks: